AGTR1 blocker attenuates activation of Tenon's capsule fibroblasts after glaucoma filtration surgery via the NF-κB signaling pathway
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 407 (1) , 112786
Abstract
No abstract availableKeywords
Funding Information
- Shanxi Provincial Key Research and Development Project (2018ZDXM-SF-045)
This publication has 44 references indexed in Scilit:
- Angiotensin II receptor type 1 blockade decreases CTGF/CCN2‐mediated damage and fibrosis in normal and dystrophic skeletal musclesJournal of Cellular and Molecular Medicine, 2011
- Neuroprotective Effects of Angiotensin II Type 1 Receptor Blocker in a Rat Model of Chronic GlaucomaInvestigative Ophthalmology & Visual Science, 2009
- Angiotensin II Activates IκB Kinase Phosphorylation of RelA at Ser536 to Promote Myofibroblast Survival and Liver FibrosisGastroenterology, 2009
- IκB kinase β (IKKβ/IKK2/IKBKB)—A key molecule in signaling to the transcription factor NF-κBCytokine & Growth Factor Reviews, 2008
- Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1receptorBritish Journal of Pharmacology, 2007
- Angiotensin II and Its Receptor Subtypes in the Human RetinaInvestigative Ophthalmology & Visual Science, 2007
- Role of Angiotensin II Receptor Subtypes in Conjunctival Wound HealingCurrent Eye Research, 2006
- Immunohistochemical Localization of Angiotensin-Converting Enzyme, Angiotensin II and AT1 Receptor in Human Ocular TissuesOphthalmic Research, 2004
- Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonistThorax, 2004
- An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cellsBritish Journal of Pharmacology, 2003